Lower lip squamous cell carcinoma in patients with photosensitive disorders : analysis of cases treated at the Brazilian National Cancer Institute (INCA) from 1999 to 2012 by Borges, Jorena-Fraga-Pimenta et al.
Med Oral Patol Oral Cir Bucal. 2018 Jan 1;23 (1):e7-12.                                                                                                                            Lower lip cancer in patients with photosensitive disorders
e7
Journal section: Oral Medicine and Pathology
Publication Types: Research
Lower lip squamous cell carcinoma in patients with photosensitive disorders: 
Analysis of cases treated at the Brazilian National Cancer Institute (INCA) 
from 1999 to 2012
Jorena-Fraga-Pimenta Borges 1, Nattália-Di Lanaro 2, Vagner-Gonçalves Bernardo 3, Rodolpho-Mattos Albano 3, 
Fernando Dias 4, Paulo-Antônio-Silvestre de Faria 5, Luis-Felipe-Ribeiro Pinto 6, Simone-de Queiroz-Chaves 
Lourenço 7
1 DDS, Programa de Residência Multiprofissional em Odontologia Oncológica. Instituto Nacional de Câncer (INCA)
2 DDS, Programa de Carcinogênese Molecular - CPQ, Instituto Nacional de Câncer (INCA)
3 PhD, Departamento de Bioquímica, Universidade do Estado do Rio de Janeiro (UERJ)
4 PhD, Departamento de Cirurgia de Cabeça e Pescoço, Instituto Nacional de Câncer (INCA)
5 MD, Divisão de Patologia, Instituto Nacional de Câncer (INCA) 
6 PhD, Programa de Carcinogênese Molecular - CPQ, Instituto Nacional de Câncer (INCA)
7 PhD, Programa de Pós-Graduação em Odontologia, Universidade Federal Fluminense (UFF)
Correspondence:
Av. das Acácias, 150, bl.01, ap. 104





Background: Lower lip squamous cell carcinoma (LLSCC) is a common malignancy of the head and neck, being 
mainly a consequence of a chronic exposure to ultraviolet (UV) light solar radiation. Here, we evaluated the clini-
copathological profile of patients with photosensitive disorders (xeroderma pigmentosum, lupus erythematosus 
and albinism) that developed LLSCC. 
Material and Methods: Data from patients who had a diagnosed LLSCC with a prior xeroderma pigmentosum, 
lupus erythematosus or albinism diagnosis that were treated at INCA from 1999 to 2012 were collected from 
patients’ medical records (n=16). The control group was composed of 68 patients with LLSCC without a medi-
cal history of photosensitivity. The clinicopathological data of this study population were collected and the as-
sociation between these variables was analyzed by Fisher’s exact test. Survival curves were constructed using 
the Kaplan–Meier method and compared by log-rank test. All statistical analyses were performed using SPSS 
statistics package.  
Results: The mean age of patients in the photosensitive and non-photosensitive groups was 42 years and 67 years, 
respectively (p<0.0001). A previous history of malignant diseases was more common in the photosensitive group 
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Introduction 
Cancer of the lip and oral cavity accounted for 300,000 
cases in 2012 (2.1% of the world’s total) (1). In Brazil, 
data from INCA (Brazilian National Cancer Institute) 
indicate that oral cancer is the fifth most common can-
cer among males and the twelfth among females, with 
15,490 new cases expected in 2016 (2).
Lip cancer arises at the junction between the oral cavity 
and the skin, appearing predominantly in white men. 
The incidence peak for lip cancer is in the seventh de-
cade of life. More than 90% of malignant tumors of the 
lip are squamous cell carcinomas (SCC) (3). 
Lip squamous cell carcinoma is one of the most common 
malignancies of the head and neck, comprising about 
12% of all cancers in this region and 25% of oral cavity 
cancers. The disease is usually diagnosed at an early 
stage, which contributes to a better prognosis (4-6).
Lip cancer is mainly a consequence of a chronic expo-
sure to ultraviolet (UV) light solar radiation, especially 
UVB, with the lower lip being the affected site in 80% 
of the cases (7). In Brazil, lip cancer is a significant 
health problem because this tropical country has a high 
incidence of UV radiation (8).
The main risk factors associated with the development 
of lower lip SCC (LLSCC) are outdoor activities, how-
ever, sociodemographic factors and lifestyle, immu-
nosuppression, tobacco and alcohol consumption, and 
even genetic susceptibility may produce a synergistic 
effect (7). In addition, an oral potentially malignant dis-
order (actinic keratosis) increase lip cancer risk (9).
In 2017, the WHO classification of Head and Neck Tu-
mors described the oral potentially malignant disorders as 
generalized clinical entities associated with a significantly 
increased risk for SCC. These include erytroplakia, ery-
troleukoplakia, leukoplakia, oral submucous fibrosis, dys-
keratosis congenita, smokeless tobacco keratosis, chronic 
candidiasis, lichen planus, discoid lupus erythematosus, 
syphilic glossitis and actinic keratosis (lip only) (9).
Here, we evaluated the clinicopathological profile of pa-
tients with xeroderma pigmentosum, lupus erythemato-
sus or albinism that developed lip SCC and were treated 
at INCA between 1999 and 2012. 
Material and Methods
-Study Design
This study was a retrospective and descriptive analysis 
of LLSCC treated at the Head and Neck Surgery Depart-
ment from 1999 to 2012. We identified five patients with 
LLSCC and albinism, four patients with LLSCC and 
lupus erythematosus and seven patients with LLSCC 
and xeroderma pigmentosum (16 patients with a prior 
photosensitivity disorder). Another 68 patients with 
LLSCC and without photosensitivity disorders were se-
lected for comparison. Patients were paired by gender. 
Clinicopathologic information on each case, including 
age, alcohol and tobacco use, pathologic stage (pTNM), 
grade of tumor differentiation (9), previous history of 
cancer before lower lip cancer diagnosis, presence or 
absence of tumor recurrence, and patient survival were 
obtained from medical records and tumor registries. 
The inclusion criterion was the availability of medical 
records. This study was reviewed and approved by the 
institutional ethics committee (CEP125/10).
-Statistical Analysis
Statistical analyses were performed using SPSS statis-
tics package for Windows (version 20.0, IBM Corp., 
Armonk, NY, USA). The association between clinico-
pathological variables was analyzed by Fisher’s exact 
test or Chi-square test. Survival analysis was done using 
the Kaplan–Meier method (the log-rank test was used to 
compare survival curves). Tests were considered statis-
tically significant when the p-value was <0.05. 
Results
Eighty-four patients were included in this study and 
their clinicopathological characteristics are shown in 
Table 1. 
There was a significant difference between the mean 
age at lower lip cancer diagnosis in the photosensitive 
group (42 ± 22.8 years, range: 11 – 77 years) and non-
photosensitive group (66.7± 14.4 years, range: 32 – 99 
years, p = 0.001). ln the photosensitive group, a posi-
tive history of previous malignancy was more common 
when compared with the non-photosensitive group (p= 
0.001). No significant difference was observed regard-
ing both alcohol consumption (p= 0.519) and tobacco 
smoking (p= 0.345).
The pTNM showed that most cases were either stage I 
or II, comprising 14 cases (87.5%) in the photosensitive 
group and 52 cases (81.2%) in the non-photosensitive 
group. There was no difference in the pathological stag-
ing between the two groups (p = 0.742). Most cases 
(p=0.001). In both groups, most tumors showed a pathological stage I/II disease. Overall and cancer-specific survival 
were not statistically different. However, disease-free interval showed a significant difference (p=0.01) between the 
photosensitive and non-photosensitive patients. 
Conclusions: Photosensitive patients presented LLSCC at earlier age but it usually was not the primary tumor in these 
patients. Furthermore, a more aggressive pathological behavior was not seen when compared with tumors from non-
photosensitive patients. The disease-free interval was lower in photosensitive patients, as expected. 
Key words: Lip cancer, Xeroderma Pigmentosum, Albinism, Lupus erythematosus.
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Table 1. Clinicopathological features of patients with LLSCC, with and without photosensitivity, treated at INCA from 1999 to 2012.
*NA - not available data; **‡  –  Chi-Square Test; ***†  –  Fisher’s Exact test
were moderately differentiated tumors and there was no 
significant difference between the groups (p=0.19).
The 5-year OS, CSS, and DFI rates were 57.4%, 57.4% 
and 37.4%, respectively, in the photosensitive group. 
The rates for the non-photosensitive group were 49.1% 
(OS), 52.6% (CSS) and 52.4% (DFI) (Table 2).
Overall survival (p=0.32) and cancer-specific survival 
(p=0.384) were not different between the two groups 
(Figs. 1,2). However, a significant lower disease-free 
interval was seen between photosensitive and non-pho-
tosensitive patients (p=0.01) (Fig. 3). 
Discussion
This paper describes a case series of 16 patients with 
photosensitive disorders that developed LLSCC in a 
tertiary cancer reference center. They were paired by 
gender because there is a clear female predominance for 
lupus erythematosus (9-11). 
The comparison between lower lip tumors from patients 
with and without photosensitivity showed a difference 
regarding the age at lip cancer diagnosis, with patients 
with photosensitivity developing lip cancer at a much 
earlier age (p<0.0001) but, generally, this cancer was 
not the primary tumor developed by these patients. 
Both groups had similar frequencies of tobacco and al-
cohol consumption, but medical records did not allow an 
accurate assessment of occupational UV-light exposure.
A previous cancer history was also significantly associ-
ated with the photosensitive patients (p=0.001). Other 
groups had already shown the development of LLSCCs 
in albino patients previously affected by skin cancer 
(12,13), and Nico and coworkers stated that patients 
with LE may present previous tumors in malar, ear and 
scalp regions (14). 
Most patients had an initial pathological stage I/II dis-
ease, irrespective of their photosensitive condition. The 
same is observed in published series of patients without 
photosensitivity. Kornevs et al. (15) and Souza et al. (8) 
showed that most patients without photosensitivity also 
had a pathological stage I/II disease (84.4% and 76.7%, 
respectively). This ‘early stage characteristic’ shows that 
LLSCC are less aggressive malignancies when com-
pared with intra-oral lesions 16, even in patients with a 
prior history of diseases related to photosensitivity. 
Tumors in our study were mostly classified histopatho-
logically as moderately differentiated (86.9%). Géraud 
et al., assessing patients without a previous history of 
photosensitive disorders found that 56% of LLSCC 
were moderately differentiated (17). Other studies such 
as Souza et al. and Biasoli et al. observed a predomi-
nance of well differentiated tumors, assessing patients 
without photosensitivity (8,18). In a study performed 
in Zimbabwe (19), well and moderately differentiated 
LLSCC were equally diagnosed in albinos, and patients 
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Fig. 2: Cancer-specific Survival. Kaplan-Meier curves for Photosensitive and Non-photosensitive Groups ac-
cording to cancer-specific survival, with no significant difference between the curves (p=0.384).
Category



















Without photosensitivity 49.1 44.0–54.2 52.6 48.1–57.0 52.4 47.2–57.3
Table 2. Survival in patients with and without photosensitivity.
Fig. 1: Overall Survival. Kaplan-Meier curves for Pho-
tosensitive and Non-photosensitive Groups according 
to overall survival, with no significant difference be-
tween the curves (p=0.32).
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Fig. 3: Disease-free interval. Kaplan-Meier curves for Photosensitive and Non-photosensitive Groups according 
to disease free interval. The presence of a photosensitive disorder indicated a lower probability of disease free 
survival (p=0.01).
with xeroderma pigmentosum developed mostly well-
differentiated LLSCCs. Another study evaluated the 
malignant potential of chronic discoid lupus erythema-
tosus, and patients that developed LLSCC had mostly 
well differentiated tumors (10). 
The disease-free interval was statistically lower in pho-
tosensitive patients (p=0.01) but cancer-specific sur-
vival showed that LLSCC did not influence survival 
(p=0.384). In our study, most photosensitive patients 
were alive after the five-year follow-up period. 
The disease-free interval was lower in photosensitive 
patients, although the overall survival, cancer-specific 
survival and pathological stage are not different be-
tween both groups. These tumors do not show a more 
aggressive behavior when compared with tumors from 
non-photosensitive patients. 
This paper reinforces the association between photosen-
sitive disorders and LLSCC development, although the 
albinism and xeroderma  pigmentosum were not cited 
as an oral potentially malignant disorder by the WHO 
(2017), its importance must be considered.
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